---
category: news
title: "BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced promising top-line data from its Phase 2 trial of BXCL701,"
publishedDateTime: 2023-01-11T12:15:00Z
originalUrl: "https://technews.tmcnet.com/news/2023/01/11/9741357.htm"
webUrl: "https://technews.tmcnet.com/news/2023/01/11/9741357.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "+BPXl0Big9JNafwbNLt0PrxkCPCp8foSdUkcnRe0aw77MmVLSqES2xTCE0lhNSXmc0C6YwPUp6d3Pfno2rxk96XLs4jnH6arw3vQjPuEUvMCIg3QgVEWTGaaR3V1dH0jVtXt+Q75OOPdBT1mxkm9I76b346n2KcgVWlYx5BdQAzNX71hWTaeIYEiFDXQ6qzEANLkk9rp/FUZ1Cu0HYzH74rqiWvNJ+9hHtWvPk7BJ/yaWI6A7EJDMhKiwhJJPVBeFFm+6KrWM7dtqL53tHBWot9A3aM3plins6YgnLRwqKVIvhemoNliPAAaghlUQN9GShoAgAXbbr7rYgknmfcMbIagW5Z9SJVMqvJfgNQN8ew=;Mvc5aDhl4lg8Bh+9Yoqjyw=="
---

